Global Metastatic Ovarian Cancer Drug Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3495519
- 89 Pages
- February 2020
- Healthcare
The global Metastatic Ovarian Cancer Drug market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Metastatic Ovarian Cancer Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
E-7449
Crizotinib
CMB-305
G-305
LV-305
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Adgero Biopharmaceuticals Inc
Cellceutix Corporation
Eisai Co., Ltd.
F. Hoffmann-La Roche Ltd.
Immune Design Corp.
Millennium Pharmaceuticals Inc
MolMed S.p.A.
Natco Pharma Limited
Northwest Biotherapeutics, Inc.
Pfizer Inc.
Richter Gedeon Nyrt.
Sumitomo Dainippon Pharma Co., Ltd.
VG Life Sciences, Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinic
Hospital
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Metastatic Ovarian Cancer Drug Industry
Figure Metastatic Ovarian Cancer Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Metastatic Ovarian Cancer Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Metastatic Ovarian Cancer Drug
1.2.2 Downstream
Table Application Segment of Metastatic Ovarian Cancer Drug
Table Global Metastatic Ovarian Cancer Drug Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Metastatic Ovarian Cancer Drug Market by Type
3.1 By Type
3.1.1 E-7449
Table Major Company List of E-7449
3.1.2 Crizotinib
Table Major Company List of Crizotinib
3.1.3 CMB-305
Table Major Company List of CMB-305
3.1.4 G-305
Table Major Company List of G-305
3.1.5 LV-305
Table Major Company List of LV-305
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Type, in USD Million
Figure Global Metastatic Ovarian Cancer Drug Market Growth 2015-2019, by Type, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Type, in Volume
Figure Global Metastatic Ovarian Cancer Drug Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Type, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Adgero Biopharmaceuticals Inc (Company Profile, Sales Data etc.)
4.1.1 Adgero Biopharmaceuticals Inc Profile
Table Adgero Biopharmaceuticals Inc Overview List
4.1.2 Adgero Biopharmaceuticals Inc Products & Services
4.1.3 Adgero Biopharmaceuticals Inc Business Operation Conditions
Table Business Operation of Adgero Biopharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Cellceutix Corporation (Company Profile, Sales Data etc.)
4.2.1 Cellceutix Corporation Profile
Table Cellceutix Corporation Overview List
4.2.2 Cellceutix Corporation Products & Services
4.2.3 Cellceutix Corporation Business Operation Conditions
Table Business Operation of Cellceutix Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Eisai Co., Ltd. (Company Profile, Sales Data etc.)
4.3.1 Eisai Co., Ltd. Profile
Table Eisai Co., Ltd. Overview List
4.3.2 Eisai Co., Ltd. Products & Services
4.3.3 Eisai Co., Ltd. Business Operation Conditions
Table Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.4.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.4.2 F. Hoffmann-La Roche Ltd. Products & Services
4.4.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Immune Design Corp. (Company Profile, Sales Data etc.)
4.5.1 Immune Design Corp. Profile
Table Immune Design Corp. Overview List
4.5.2 Immune Design Corp. Products & Services
4.5.3 Immune Design Corp. Business Operation Conditions
Table Business Operation of Immune Design Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Millennium Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.6.1 Millennium Pharmaceuticals Inc Profile
Table Millennium Pharmaceuticals Inc Overview List
4.6.2 Millennium Pharmaceuticals Inc Products & Services
4.6.3 Millennium Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Millennium Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 MolMed S.p.A. (Company Profile, Sales Data etc.)
4.7.1 MolMed S.p.A. Profile
Table MolMed S.p.A. Overview List
4.7.2 MolMed S.p.A. Products & Services
4.7.3 MolMed S.p.A. Business Operation Conditions
Table Business Operation of MolMed S.p.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Natco Pharma Limited (Company Profile, Sales Data etc.)
4.8.1 Natco Pharma Limited Profile
Table Natco Pharma Limited Overview List
4.8.2 Natco Pharma Limited Products & Services
4.8.3 Natco Pharma Limited Business Operation Conditions
Table Business Operation of Natco Pharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Northwest Biotherapeutics, Inc. (Company Profile, Sales Data etc.)
4.9.1 Northwest Biotherapeutics, Inc. Profile
Table Northwest Biotherapeutics, Inc. Overview List
4.9.2 Northwest Biotherapeutics, Inc. Products & Services
4.9.3 Northwest Biotherapeutics, Inc. Business Operation Conditions
Table Business Operation of Northwest Biotherapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Pfizer Inc. (Company Profile, Sales Data etc.)
4.10.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.10.2 Pfizer Inc. Products & Services
4.10.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Richter Gedeon Nyrt. (Company Profile, Sales Data etc.)
4.11.1 Richter Gedeon Nyrt. Profile
Table Richter Gedeon Nyrt. Overview List
4.11.2 Richter Gedeon Nyrt. Products & Services
4.11.3 Richter Gedeon Nyrt. Business Operation Conditions
Table Business Operation of Richter Gedeon Nyrt. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Sumitomo Dainippon Pharma Co., Ltd. (Company Profile, Sales Data etc.)
4.12.1 Sumitomo Dainippon Pharma Co., Ltd. Profile
Table Sumitomo Dainippon Pharma Co., Ltd. Overview List
4.12.2 Sumitomo Dainippon Pharma Co., Ltd. Products & Services
4.12.3 Sumitomo Dainippon Pharma Co., Ltd. Business Operation Conditions
Table Business Operation of Sumitomo Dainippon Pharma Co., Ltd. (Sales Revenue, Cost, Gross Margin)
4.13 VG Life Sciences, Inc. (Company Profile, Sales Data etc.)
4.13.1 VG Life Sciences, Inc. Profile
Table VG Life Sciences, Inc. Overview List
4.13.2 VG Life Sciences, Inc. Products & Services
4.13.3 VG Life Sciences, Inc. Business Operation Conditions
Table Business Operation of VG Life Sciences, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Metastatic Ovarian Cancer Drug Sales Revenue 2015-2019, by Company, in USD Million
Table Global Metastatic Ovarian Cancer Drug Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Metastatic Ovarian Cancer Drug Sales Revenue Share in 2019, by Company, in USD Million
Table Global Metastatic Ovarian Cancer Drug Sales Volume 2015-2019, by Company, in Volume
Table Global Metastatic Ovarian Cancer Drug Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Metastatic Ovarian Cancer Drug Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Metastatic Ovarian Cancer Drug Market Concentration, in 2019
Figure Europe Metastatic Ovarian Cancer Drug Market Market Concentration, in 2019
Figure Asia-Pacific Metastatic Ovarian Cancer Drug MMarket Concentration, in 2019
Figure South America Metastatic Ovarian Cancer Drug Market Concentration, in 2019
Figure Middle East & Africa Metastatic Ovarian Cancer Drug Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Metastatic Ovarian Cancer Drug Demand in Clinic, 2015-2019, in USD Million
Figure Metastatic Ovarian Cancer Drug Demand in Clinic, 2015-2019, in Volume
6.1.2 Demand in Hospital
Figure Metastatic Ovarian Cancer Drug Demand in Hospital, 2015-2019, in USD Million
Figure Metastatic Ovarian Cancer Drug Demand in Hospital, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Metastatic Ovarian Cancer Drug Demand in Others, 2015-2019, in USD Million
Figure Metastatic Ovarian Cancer Drug Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Metastatic Ovarian Cancer Drug Demand Forecast 2020-2025, by Application, in USD Million
Figure Metastatic Ovarian Cancer Drug Market Growth 2020-2025, by Application, in USD Million
Figure Metastatic Ovarian Cancer Drug Market Share in 2025, by Application, in USD Million
Table Metastatic Ovarian Cancer Drug Demand Forecast 2020-2025, by Application, in Volume
Table Metastatic Ovarian Cancer Drug Market Growth 2020-2025, by Application, in Volume
Table Metastatic Ovarian Cancer Drug Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Metastatic Ovarian Cancer Drug Production 2015-2019, by Region, in USD Million
Table Metastatic Ovarian Cancer Drug Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Region, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market Share 2015-2019, by Region, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Region, in Volume
Table Global Metastatic Ovarian Cancer Drug Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in USD Million
Figure North America Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table North America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in USD Million
Figure Europe Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table Europe Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in USD Million
Figure South America Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table South America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Metastatic Ovarian Cancer Drug Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Region, in USD Million
Table Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Metastatic Ovarian Cancer Drug
Table Application Segment of Metastatic Ovarian Cancer Drug
Table Global Metastatic Ovarian Cancer Drug Market 2015-2025, by Application, in USD Million
Table Major Company List of Crizotinib
Table Major Company List of CMB-305
Table Major Company List of G-305
Table Major Company List of LV-305
Table Major Company List of Others
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Type, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Type, in Volume
Table Global Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Type, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Type, in Volume
Table Adgero Biopharmaceuticals Inc Overview List
Table Business Operation of Adgero Biopharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cellceutix Corporation Overview List
Table Business Operation of Cellceutix Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Co., Ltd. Overview List
Table Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Immune Design Corp. Overview List
Table Business Operation of Immune Design Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Millennium Pharmaceuticals Inc Overview List
Table Business Operation of Millennium Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MolMed S.p.A. Overview List
Table Business Operation of MolMed S.p.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Natco Pharma Limited Overview List
Table Business Operation of Natco Pharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Northwest Biotherapeutics, Inc. Overview List
Table Business Operation of Northwest Biotherapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Richter Gedeon Nyrt. Overview List
Table Business Operation of Richter Gedeon Nyrt. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sumitomo Dainippon Pharma Co., Ltd. Overview List
Table Business Operation of Sumitomo Dainippon Pharma Co., Ltd. (Sales Revenue, Cost, Gross Margin)
Table VG Life Sciences, Inc. Overview List
Table Business Operation of VG Life Sciences, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Metastatic Ovarian Cancer Drug Sales Revenue 2015-2019, by Company, in USD Million
Table Global Metastatic Ovarian Cancer Drug Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Metastatic Ovarian Cancer Drug Sales Volume 2015-2019, by Company, in Volume
Table Global Metastatic Ovarian Cancer Drug Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Metastatic Ovarian Cancer Drug Demand Forecast 2020-2025, by Application, in USD Million
Table Metastatic Ovarian Cancer Drug Demand Forecast 2020-2025, by Application, in Volume
Table Metastatic Ovarian Cancer Drug Market Growth 2020-2025, by Application, in Volume
Table Metastatic Ovarian Cancer Drug Market Share in 2025, by Application, in Volume
Table Metastatic Ovarian Cancer Drug Production 2015-2019, by Region, in USD Million
Table Metastatic Ovarian Cancer Drug Production 2015-2019, by Region, in Volume
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Region, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market Share 2015-2019, by Region, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market 2015-2019, by Region, in Volume
Table Global Metastatic Ovarian Cancer Drug Market Share 2015-2019, by Region, in Volume
Table North America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table North America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
Table Europe Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table Europe Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
Table South America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table South America Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Metastatic Ovarian Cancer Drug Market Size 2015-2019, by Country, in Volume
Table Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Region, in USD Million
Table Metastatic Ovarian Cancer Drug Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
